Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
IncomeQ Nasdaq-100 Premium Income ETF
Quaker Houghton Common Stock
STKd 100% UBER & 100% TSLA ETF
Titan Acquisition Corp. - Class A Ordinary Shares
Titan Acquisition Corp. - Warrants
Edit Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Articles published by Polpharma Biologics International AG
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
July 31, 2026
From
Polpharma Biologics International AG
Via
Business Wire
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis
July 09, 2026
From
Polpharma Biologics International AG
Via
Business Wire
Tickers
TEVA
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.